-
Michel Sadelain (born 1960) is a
genetic engineer and cell
therapist at
Columbia University New York, New York. He is the
Director of the
Columbia Initiative...
- (8): 494–502. doi:10.1016/j.it.2015.06.004. PMC 4746114. PMID 26169254.
Sadelain M,
Brentjens R, Rivière I (April 2013). "The
basic principles of chimeric...
- been
shown to
induce islet beta cell regeneration.
Immunologic adjuvant Sadelain, MW; Qin, HY; Lauzon, J; Singh, B (1990), "Prevention of type I diabetes...
-
Rosenberg (born 1940) United
States National Cancer Institute Michel Sadelain (born 1960) United
States Memorial Sloan Kettering Cancer Center Rob Knight...
- 365 (8): 725–733. doi:10.1056/nejmoa1103849. PMC 3387277. PMID 21830940.
Sadelain M (December 2017). "CD19 CAR T Cells". Cell. 171 (7): 1471. doi:10.1016/j...
- 2010-0441. PMC 5393383. PMID 20668043.
Chang AH,
Stephan MT,
Lisowski L,
Sadelain M (2008). "Erythroid-specific
human factor IX
delivery from in vivo selected...
-
Mendelsohn Rosen James Rothman Alexander Rudensky Valerie Rusch Michel Sadelain Charles Sawyers Lorenz Studer In 2015,
Charity Watch rated Memorial Sloan...
-
blood cancer 2024 - Vin****ure Prize,
alongside Zelig Eshhar, and
Michel Sadelain for the
development and
advancement of CAR T cell therapy. "June Lab"....
-
Outstanding Achievements in
Emerging Fields alongside Carl H. June and
Michel Sadelain for
their contributions to the
development and
advancement of CAR T cell...
- 145 (2): dev148874. doi:10.1242/dev.148874. PMID 29374062.
Themeli M,
Sadelain M (April 2016). "Combinatorial
Antigen Targeting:
Ideal T-Cell Sensing...
